rs3743674

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The c.48+6C>T variant has an allele frequency of 0.81161 (81%, 129,383/159,416 alleles) in the gnomAD cohort (BA1). Therefore, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA200462/MONDO:0007648/007

Frequency

Genomes: 𝑓 0.80 ( 50036 hom., cov: 35)
Exomes 𝑓: 0.87 ( 522253 hom. )

Consequence

CDH1
NM_004360.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00001643
2

Clinical Significance

Benign reviewed by expert panel U:1B:24

Conservation

PhyloP100: -0.132

Publications

48 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.48+6C>T
splice_region intron
N/ANP_004351.1A0A0U2ZQU7
CDH1
NM_001317184.2
c.48+6C>T
splice_region intron
N/ANP_001304113.1P12830-2
CDH1
NM_001317185.2
c.-1568+6C>T
splice_region intron
N/ANP_001304114.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.48+6C>T
splice_region intron
N/AENSP00000261769.4P12830-1
CDH1
ENST00000422392.6
TSL:1
c.48+6C>T
splice_region intron
N/AENSP00000414946.2P12830-2
CDH1
ENST00000566612.5
TSL:1
n.48+6C>T
splice_region intron
N/AENSP00000454782.1H3BNC6

Frequencies

GnomAD3 genomes
AF:
0.805
AC:
122401
AN:
152054
Hom.:
50031
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.663
Gnomad AMI
AF:
0.924
Gnomad AMR
AF:
0.799
Gnomad ASJ
AF:
0.930
Gnomad EAS
AF:
0.773
Gnomad SAS
AF:
0.784
Gnomad FIN
AF:
0.825
Gnomad MID
AF:
0.850
Gnomad NFE
AF:
0.884
Gnomad OTH
AF:
0.831
GnomAD2 exomes
AF:
0.816
AC:
108886
AN:
133422
AF XY:
0.820
show subpopulations
Gnomad AFR exome
AF:
0.647
Gnomad AMR exome
AF:
0.741
Gnomad ASJ exome
AF:
0.928
Gnomad EAS exome
AF:
0.765
Gnomad FIN exome
AF:
0.827
Gnomad NFE exome
AF:
0.878
Gnomad OTH exome
AF:
0.857
GnomAD4 exome
AF:
0.867
AC:
1200027
AN:
1384830
Hom.:
522253
Cov.:
45
AF XY:
0.865
AC XY:
591464
AN XY:
684018
show subpopulations
African (AFR)
AF:
0.652
AC:
20479
AN:
31398
American (AMR)
AF:
0.756
AC:
27499
AN:
36368
Ashkenazi Jewish (ASJ)
AF:
0.929
AC:
23342
AN:
25138
East Asian (EAS)
AF:
0.765
AC:
27424
AN:
35852
South Asian (SAS)
AF:
0.778
AC:
61563
AN:
79162
European-Finnish (FIN)
AF:
0.837
AC:
29015
AN:
34660
Middle Eastern (MID)
AF:
0.835
AC:
3440
AN:
4118
European-Non Finnish (NFE)
AF:
0.886
AC:
957646
AN:
1080310
Other (OTH)
AF:
0.858
AC:
49619
AN:
57824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
8095
16190
24286
32381
40476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20952
41904
62856
83808
104760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.805
AC:
122443
AN:
152170
Hom.:
50036
Cov.:
35
AF XY:
0.800
AC XY:
59502
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.663
AC:
27507
AN:
41508
American (AMR)
AF:
0.799
AC:
12229
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.930
AC:
3228
AN:
3470
East Asian (EAS)
AF:
0.773
AC:
3989
AN:
5162
South Asian (SAS)
AF:
0.784
AC:
3782
AN:
4826
European-Finnish (FIN)
AF:
0.825
AC:
8740
AN:
10596
Middle Eastern (MID)
AF:
0.849
AC:
248
AN:
292
European-Non Finnish (NFE)
AF:
0.884
AC:
60127
AN:
67988
Other (OTH)
AF:
0.828
AC:
1750
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1183
2365
3548
4730
5913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
876
1752
2628
3504
4380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.849
Hom.:
10832
Bravo
AF:
0.796
Asia WGS
AF:
0.774
AC:
2692
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
9
not specified (9)
-
-
5
Hereditary diffuse gastric adenocarcinoma (5)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
1
2
not provided (3)
-
-
2
Prostate cancer (2)
-
-
1
Blepharocheilodontic syndrome 1 (1)
-
-
1
CDH1-related diffuse gastric and lobular breast cancer syndrome (1)
-
-
1
Familial cancer of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.2
DANN
Benign
0.92
PhyloP100
-0.13
PromoterAI
-0.063
Neutral
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000016
dbscSNV1_RF
Benign
0.032
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3743674; hg19: chr16-68771372; COSMIC: COSV55733220; API